Safety and Efficacy of Empagliflozin in Hemodialysis

Clinical trial NCT05786443 · RECRUITING

Trial details

NCT number: NCT05786443
Sponsor: NYU Langone Health
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

End Stage Renal Disease

Start date: 2024-01-31
Primary completion: 2026-12-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.